A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
Sarojani Angal(Cell Technology (China)), John R. Adair(UCB Pharma (United Kingdom)), Gerald D. Roberts(UCB Pharma (United Kingdom)), R. Barbara Pedley(The Royal Free Hospital), David J. King(AnaBios (United States)), A.D.G. Lawson(UCB Pharma (United Kingdom)), Mark Bodmer(UCB Pharma (United Kingdom)), Alison Turner(UCB Pharma (United Kingdom))
Cited by 243
Related Papers
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
|Nature Biotechnology|1992|465
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis
|Critical Care Medicine|1993|431
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
|PubMed|1996|212
Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3
|Protein Engineering Design and Selection|1994|122